Mitochondria emerge as the central hub linking cell death and metabolism in gum disease

Periodontitis, the chronic inflammatory disease that destroys the tissues anchoring our teeth, has long been treated as a story about bacteria and the immune cells that fight them. A new review published in Molecular Biology Reports argues that this story is incomplete. Tengyi Zheng of Guangdong Pharmaceutical University and colleagues propose that mitochondria, the energy-producing organelles inside our cells, sit at the center of a self-reinforcing pathological loop that connects two processes increasingly implicated in gum destruction: ferroptosis, an iron-dependent form of regulated cell death, and metabolic reprogramming, the wholesale rewiring of how cells consume nutrients and generate energy. The review, published on 5 September 2026, weaves together evidence from cell biology, metabolomics and nanomedicine into a single mechanistic framework with direct implications for why periodontitis so often resists treatment and recurs.

The core claim of the paper is deceptively simple: periodontal pathogens such as Porphyromonas gingivalis inflict structural and functional collapse on mitochondria, and this collapse cascades outward into disturbances of iron, lipid, amino acid and glucose metabolism. Those metabolic disturbances, in turn, create the biochemical conditions for ferroptosis, which is driven by the accumulation of lipid peroxides in cell membranes when antioxidant defenses fail. Once ferroptosis takes hold, dying cells release damage-associated molecular patterns and iron that further injure mitochondria in neighboring cells, closing a vicious cycle. The authors argue that this mitochondria-metabolism-ferroptosis axis is the unifying mechanism underlying the refractory inflammation and sustained alveolar bone resorption that characterize advanced disease.

Ferroptosis itself is a relatively recent addition to the cell death lexicon. Unlike apoptosis, which is orderly and immunologically quiet, or necroptosis and pyroptosis, which are loudly inflammatory, ferroptosis is defined biochemically: it requires iron, depends on the oxidation of polyunsaturated fatty acids within membrane phospholipids, and can be suppressed by the glutathione-dependent enzyme GPX4, which detoxifies lipid hydroperoxides. Mitochondria are deeply entangled in this process. They are the major source of reactive oxygen species in most cells, they import iron through the mitoferrin transporters, and they carry out the citric acid cycle reactions that generate the metabolic intermediates needed for lipid synthesis. When mitochondrial membranes are damaged, electron leakage from the respiratory chain accelerates peroxide production, and the cell slides toward ferroptotic death.

The review assembles considerable evidence that this form of death is active in periodontal tissues. Periodontitis-level concentrations of butyrate, a short-chain fatty acid produced by dysbiotic subgingival bacteria, induce ferroptosis in periodontal ligament fibroblasts by activating ferritinophagy, the autophagic degradation of ferritin that liberates free iron inside the cell. P. gingivalis infection has been shown to impair epithelial junctions in the gingival barrier partly through ferroptotic death of epithelial cells, compromising the first line of defense against the bacterial biofilm. Lipidomic analyses of gingival tissue from patients with periodontitis reveal altered lipid profiles consistent with peroxidation, and clinical studies document elevated oxidant capacity and depressed antioxidant capacity in gingival crevicular fluid and saliva. Iron itself appears to be a plausible driver: patients with genetic hemochromatosis, who carry high transferrin saturation, show more severe periodontitis and altered subgingival microbiota, and iron overload worsens periodontal status in sickle cell anemia.

Metabolic reprogramming is the other half of the axis, and the review treats it not as a background phenomenon but as an active participant in disease. Immune cells in the inflamed gingiva shift their metabolism dramatically. Pro-inflammatory macrophages rely heavily on glycolysis rather than oxidative phosphorylation, a switch that supports rapid ATP generation and the biosynthesis of inflammatory mediators, while tissue-resident macrophage homeostasis depends on intact oxidative phosphorylation. P. gingivalis and its outer membrane vesicles have been shown to remodel macrophage metabolism and activate the inflammasome, promoting pyroptotic death that further fuels inflammation. In fibroblasts and stem cells, hypoxia-inducible factor 1 alpha, which can be induced by bacterial lipopolysaccharide even without true hypoxia, drives glycolytic genes and alters extracellular matrix remodeling. In osteoclasts, the bone-resorbing cells whose overactivity destroys alveolar bone, glutaminolysis supplies the nucleotides and amino acids needed for differentiation, and impairment of PINK1-mediated mitophagy removes a brake on bone loss.

The amino acid dimension of this rewiring is particularly rich. Tryptophan metabolism along the kynurenine pathway modulates macrophage behavior through the aryl hydrocarbon receptor and NRF2, and microbial indole derivatives from the tryptophan pathway can either ameliorate or exacerbate periodontal inflammation depending on the metabolite. P. gingivalis infection raises circulating branched-chain amino acids in mice, contributing to insulin resistance, a finding that helps explain the tight bidirectional association between periodontitis and diabetes. Arginine metabolism feeds nitric oxide and polyamine synthesis, and recent cancer studies show that arginine-derived fumarate can accelerate ferroptosis while protein arginine methyltransferases stabilize GPX4 to suppress it, suggesting that arginine metabolism is a genuine regulatory node in the ferroptosis network rather than a passive bystander. Salivary amino acid profiles differ measurably between healthy individuals and periodontitis patients, and methylated arginine metabolites correlate with oxidative stress in advanced disease.

Iron and lipid metabolism complete the picture. The review highlights that upregulated ferritin in periodontitis promotes inflammatory cytokine expression in periodontal ligament cells through the transferrin receptor and ERK and p38 MAPK signaling, meaning that the iron storage protein itself becomes an inflammatory signal. Copper, too, has emerged as a ferroptosis modulator, with copper-dependent autophagic degradation of GPX4 shown to drive ferroptotic death in cancer cells, and the authors note that cuproptosis, a copper-dependent death pathway, may intersect with ferroptosis in periodontal tissues. On the lipid side, altered lipidomic profiles in gingival tissue, epidemiological links between dyslipidemia and chronic periodontitis, and experimental evidence that periodontal bacteria promote hepatic lipogenesis all suggest that lipid supply determines how much peroxidizable substrate is available for ferroptotic membrane destruction.

What elevates the review beyond a literature synthesis is its translational framework. If mitochondria are the hub, the authors reason, then mitochondria-targeted therapies should break the vicious cycle more effectively than broad anti-inflammatory approaches. The evidence base they survey is striking. Mdivi-1, an inhibitor of the fission protein Drp1, protects periodontal ligament cells from nicotine-induced injury by preventing excessive mitochondrial fission. Activation of PGC-1 alpha-dependent mitochondrial biogenesis underlies the therapeutic effects of silibinin in diabetic periodontitis, while genipin attenuates oxidative damage by inhibiting UCP2 and correcting abnormal glucose uptake. Hydroxytyrosol prevents periodontitis-induced bone loss by regulating mitochondrial function in bone cells, and isobavachin attenuates osteoclastogenesis by inhibiting cellular iron accumulation and mitochondrial biogenesis simultaneously, a dual action that maps neatly onto the proposed axis.

Nanomedicine features prominently in the therapeutic outlook because the mitochondrion is a difficult target for conventional drugs. Recent platforms described in the review include mitochondria-targeted ROS-scavenging enzyme cascade nanogels that alleviate hypoxia and modulate immunity, a hierarchically targeting and ROS-responsive platform that repairs mitochondria in M1 macrophages for diabetic periodontitis, a mitochondria-targeted injectable hydrogel that regulates oral immunity and flora, an H2S-scavenging hydrogel that reduces mitochondrial damage, mitochondrial calcium ion nanogluttons that control mitochondrial permeability transition pores, and a manganese dioxide coupled metal-organic framework that acts as a mitophagy regulator through the SIRT1-FOXO3-BNIP3 axis. A thermosensitive ionic liquid hydrogel based on galangin and L-cysteine-decorated MoS2 nanoflowers has been used to tailor ferroptosis regulation directly in periodontal lesions. Together these systems illustrate a shift from killing bacteria to rescuing organelles.

The authors are careful to frame their proposal as a unifying hypothesis rather than a settled fact, and the field will need causal studies, ideally with mitochondrial rescue experiments in animal models, to confirm that breaking the cycle at the mitochondrial hub is sufficient to halt bone loss. Even so, the framework offers a coherent explanation for two of the most frustrating features of periodontitis: its resistance to conventional therapy and its tendency to recur. If ferroptotic death and metabolic dysregulation continuously re-injure mitochondria, then treating infection alone leaves the degenerative machinery running. A therapeutic strategy that restores mitochondrial integrity, restrains iron-mediated lipid peroxidation and normalizes metabolic signaling could, in principle, convert a self-sustaining destructive process back into resolvable inflammation. For a disease affecting nearly half the adult population worldwide and increasingly linked to diabetes, cardiovascular disease and neurodegeneration, that reframing may prove to be the review’s most consequential contribution.

Subject of Research: The role of mitochondria as a central hub connecting ferroptosis and metabolic reprogramming in periodontitis pathogenesis

Article Title: Mitochondrial hub: the integrative axis connecting ferroptosis and metabolic reprogramming in periodontitis

Article References: Zheng, T., Zhang, Z., Lu, F., Chen, Y., Zhou, P., Zhang, R., & Li, X. (2026). Mitochondrial hub: the integrative axis connecting ferroptosis and metabolic reprogramming in periodontitis. Molecular Biology Reports, 53(1), Article 1539. https://doi.org/10.1007/s11033-026-12719-5

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12719-5

Keywords: periodontitis, ferroptosis, mitochondria, metabolic reprogramming, Porphyromonas gingivalis, lipid peroxidation, iron metabolism, GPX4, mitophagy, nanomedicine, alveolar bone loss, oxidative stress